Search - tctmd.com

Displaying 561 - 580 of 1277

Sort: Relevancy | Date

News Daily News

CABG Mejor que PCI en Pacientes a Diálisis con Enfermedad Coronaria Compleja

Caitlin E. Cox

June 24, 2014

Presentation

PCI vs CABG in Patients with End-Stage Renal Disease Requiring Dialysis

Presenter: Akira Marui

June 20, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Daily News

Un Injerto de Stent en Fase de Investigación resulta Prometedor en la EVAR de AAA Infrarrenales

L.A. McKeown

June 11, 2014

News Daily News

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

Yael L. Maxwell

June 11, 2014

News Daily News

SYMPLICITY HTN-2: La Denervación Renal es Segura y Eficaz a los 3 Años

Yael L. Maxwell

June 11, 2014

News Daily News

Investigational Stent Graft Shows Promise in EVAR for Infrarenal AAA

L.A. McKeown

June 11, 2014

Presentation

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

Presenter: Murray D. Esler

June 10, 2014

News Daily News

Initial Kidney Protection of Off-Pump CABG May Not Last

Caitlin E. Cox

June 04, 2014

News Daily News

Preprocedural Patient Factors Useful for Predicting Poor Outcome Following TAVR

L.A. McKeown

June 03, 2014

News Industry News

Cardiovascular Systems Coronary Data Highlighted in Late-Breaking Presentation at EuroPCR Conference

June 02, 2014

News Daily News

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

May 30, 2014

News Daily News

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

May 30, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Caitlin E. Cox

May 23, 2014

News Industry News

Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure

May 23, 2014

Presentation EuroPCR 2014

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

May 22, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Industry News

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

Advertisement

CABG Mejor que PCI en Pacientes a Diálisis con Enfermedad Coronaria Compleja

PCI vs CABG in Patients with End-Stage Renal Disease Requiring Dialysis

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

Un Injerto de Stent en Fase de Investigación resulta Prometedor en la EVAR de AAA Infrarrenales

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

SYMPLICITY HTN-2: La Denervación Renal es Segura y Eficaz a los 3 Años

Investigational Stent Graft Shows Promise in EVAR for Infrarenal AAA

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

Initial Kidney Protection of Off-Pump CABG May Not Last

Preprocedural Patient Factors Useful for Predicting Poor Outcome Following TAVR

Cardiovascular Systems Coronary Data Highlighted in Late-Breaking Presentation at EuroPCR Conference

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content